Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2024-04-24 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
关于聘请2024年度审计机构的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the appointment of the audit firm for the fiscal year 2024. It details the decision made by the board and audit committee to hire a specific accounting firm for auditing the company's financials and internal controls. It does not contain any actual financial statements, audit results, or detailed audit reports. The document is relatively short (2822 characters) and serves as a formal notice of the audit firm appointment, which is typically a regulatory announcement rather than the audit report itself. Therefore, it fits best under the category of Regulatory Filings (RNS), as it is an official disclosure about audit firm appointment without substantive financial data or audit results.
2024-04-24 Chinese
2023年度监事会工作报告
Management Reports Classification · 95% confidence The document is titled as the "2023年度监事会工作报告" which translates to "2023 Supervisory Board Work Report". It details the supervisory board's activities, oversight of company operations, financial management, internal controls, and compliance with laws and regulations during the 2023 fiscal year. It includes summaries of meetings, audit opinions, internal control evaluations, and future plans. The document is a formal report from the supervisory board rather than an announcement or a brief summary. It does not contain full financial statements like an Annual Report (10-K) or Interim Report (IR), nor is it a certification or a voting result announcement. It is a detailed management oversight report, which fits best under Management Reports (MDA). The document length is 3144 characters, which is relatively short but contains substantive content about management oversight and company governance activities, not just an announcement or notice. Therefore, the most appropriate classification is Management Reports (MDA).
2024-04-24 Chinese
2023年度营业收入扣除事项的专项核查报告
Audit Report / Information Classification · 95% confidence The document is a specialized audit report titled '2023年度营业收入扣除事项的专项核查报告' (Special Audit Report on Revenue Deduction Items for 2023) issued by an accounting firm. It references the 2023 fiscal year and includes detailed examination and verification of revenue deduction items in accordance with Shenzhen Stock Exchange listing rules. The document contains audit opinions, responsibilities of management and auditors, and detailed financial tables related to revenue deductions. It is not a full annual report but a standalone audit-related report focusing on a specific aspect of the financials (revenue deductions). The document length is under 5,000 characters but it is a substantive audit report, not merely an announcement or certification. Therefore, it fits the category of Audit Report / Information (AR). FY 2023
2024-04-24 Chinese
董事会决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 8th meeting of the 10th Board of Directors of the company, including approval of the 2023 Annual Report, 2023 Annual Financial Statements, Board and General Manager Work Reports, Internal Control Evaluation Report, appointment of the 2024 audit firm, and other governance matters. It repeatedly states that the full reports are published separately on the official information disclosure website (巨潮资讯网) and various newspapers, indicating this document itself is not the full annual report but a board meeting resolution announcement. The document also mentions that these reports will be submitted to the 2023 Annual General Meeting for approval. The document length is 4336 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full annual report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an official announcement of board meeting resolutions and not the full annual report or financial statements themselves.
2024-04-24 Chinese
关于2024年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding its expected related party transactions for the year 2024. It includes detailed tables of transaction types, amounts, counterparties, and pricing principles. It also contains information about the related parties, their financial status, and the company's board meeting resolutions approving these transactions. The document is titled as an announcement and does not contain comprehensive financial statements or detailed financial performance data. It is a regulatory disclosure about related party transactions, which is a typical regulatory filing to inform shareholders and the market about potential conflicts of interest and transaction volumes. The document length is 4345 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication that this is an annual report, interim report, earnings release, or any other detailed financial report. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-04-24 Chinese
2023年度财务决算报告
Annual Report Classification · 95% confidence The document is titled '2023 年度财务决算报告' which translates to '2023 Annual Financial Settlement Report'. It contains detailed financial data for the full year 2023, including income statement, balance sheet, cash flow statement, and notes. It also includes auditor's report with an unqualified opinion, detailed analysis of business performance, expenses, asset impairments, and cash flow analysis. The document length is 3857 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or certification. The content matches the characteristics of an Annual Report (10-K) as it covers the full fiscal year financial performance and audited financial statements. Therefore, the document should be classified as an Annual Report (10-K). FY 2023
2024-04-24 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.